Fivos has selected Carta Healthcare as its partner for clinical data abstraction, leveraging Carta Healthcare's hybrid intelligence platform and team of expert clinical abstractors to enhance the ...

Intermountain Health, the largest nonprofit healthcare provider in the Intermountain West region, struck a multi-year collaboration with a young generative AI startup this month. The health system is ...

The central promise of precision medicine is to provide right-sized and personalized care, patient by patient, instead of hewing to a singular clinical pathway for all patients who have a particular ...

SALT LAKE CITY, Nov. 2, 2023 /PRNewswire/ -- Health Catalyst, Inc. ("Health Catalyst," Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, ...

Interview on Ontada research presented at ISPOR 2024. Use of real-world data in research demands that data pulled from electronic health records are accurate. New research from Ontada shows how doing ...

This philosophical insight, which strongly resonates with modern research on computational creativity and cognitive expertise, reveals the true essence of Health AI: it is not a technological platform ...

Longitudinal MRI-based radiomic model to complement sentinel lymph node biopsy assessment after neoadjuvant chemotherapy in initially clinically node-positive breast cancer: A multicentre, diagnostic ...

Dr. Suruchi Kothari, BSc, MD, MRCGP, MSx: Health tech innovator reshaping clinical care. Driven by a tech-forward, patient-centric approach. Imagine a healthcare system where a patient's heart monitor ...

Nashville, Tenn.-based Vanderbilt University Medical Center has received a $2 million federal grant to expand deployment of an AI-powered data extraction tool. HHS’ Advanced Research Projects Agency ...

Knowing patient survival rates is critical to informing research and care delivery, particularly in the oncology space. But what if survival data is inaccurate or incomplete? Well, that could ...

Oct 18 (Reuters) - Shares in AstraZeneca (AZN.L), opens new tab fell more than 4% on Wednesday after a data abstract on its experimental precision drug's use in lung cancer patients in a late-stage ...